Novo Nordisk A/S (NVO) Drops as New Eli Lilly and Company (LLY) Drug Threatens Victoza
6/17/2013 10:05:30 AM
More...
|
Novo Nordisk A/S (NVO) Release: Victoza® (Liraglutide [rDNA Origin] Injection) Safety Profile Further Supported at Scientific Workshop on Pancreatitis, Diabetes and Pancreatic Cancer
6/14/2013 9:55:04 AM
More...
|
Merck & Co., Inc. (MRK) Joins Novo Nordisk A/S (NVO) to Reassure Safety of Diabetes Drugs
6/12/2013 7:52:20 AM
More...
|
Novo Nordisk A/S (NVO) Files for Regulatory Approval of IDegLira in the EU for the Treatment of Type 2 Diabetes
5/31/2013 12:44:47 PM
More...
|
Novo Nordisk A/S (NVO) Says Obesity Drug Trial Confirms Weight Loss
5/23/2013 11:32:37 AM
More...
|
Novo Nordisk A/S (NVO) Reports Positive Results From First Phase 3 Trial With Long-Acting Factor IX for Treatment of Hemophilia B
5/17/2013 10:18:53 AM
More...
|
Novo Nordisk A/S (NVO) Invests $69 Million in Plant, Creating 50 New Production/Engineering Jobs
5/7/2013 7:35:35 AM
More...
|
Novo Nordisk A/S (NVO) - Share Repurchase Program
5/6/2013 11:11:49 AM
More...
|
Novo Nordisk A/S (NVO) Purchases B Shares Worth DKK 2.5 Billion From Novo A/S as Part of the On-Going Share Repurchase Program
5/6/2013 10:47:28 AM
More...
|
Novo Nordisk A/S (NVO) Increased Operating Profit by 18 Pct in the First Quarter of 2013
5/1/2013 11:50:11 AM
More...
|
|